Provides for funding to currently eligible Medicaid recipients for physician and laboratory services targeted to SCD that are not currently reimbursed or under-reimbursed by Medicaid; Permits States to receive a federal 50-50 funding match for non-medical expenses related to SCD treatment such as genetic counseling, community outreach, education and other services.